Investigation of the effects of some sulfonamides on acetylcholinesterase and carbonic anhydrase enzymes

Journal of Biochemical and Molecular Toxicology
Zeynep KöksalHasan Özdemir

Abstract

Human carbonic anhydrase I and II isoenzymes (hCA I and II) and acetylcholinesterase (AChE) are important metabolic enzymes that are closely associated with various physiological and pathological processes. In this study, we investigated the inhibition effects of some sulfonamides on hCA I, hCA II, and AChE enzymes. Both hCA isoenzymes were purified by Sepharose-4B-L-Tyrosine-5-amino-2-methylbenzenesulfonamide affinity column chromatography with 1393.44 and 1223.09-folds, respectively. Also, some inhibition parameters including IC50 and Ki values were determined. Sulfonamide compounds showed IC 50 values of in the range of 55.14 to 562.62 nM against hCA I, 55.99 to 261.96 nM against hCA II, and 98.65 to 283.31 nM against AChE. Ki values were in the range of 23.40 ± 9.10 to 365.35 ± 24.42 nM against hCA I, 45.87 ± 5.04 to 230.08 ± 92.23 nM against hCA II, and 16.00 ± 45.53 to 157.00 ± 4.02 nM against AChE. As a result, sulfonamides had potent inhibition effects on these enzymes. Therefore, we believe that these results may contribute to the development of new drugs particularly in the treatment of some disorders.

References

Apr 4, 2000·Physiological Reviews·C Geers, G Gros
Jul 1, 1961·Biochemical Pharmacology·G L ELLMANR M FEATHER-STONE
Feb 3, 2004·Current Pharmaceutical Design·Bernd Ibach, Ekkehard Haen
Aug 3, 2010·Bioorganic & Medicinal Chemistry Letters·Alessio InnocentiClaudiu T Supuran
Feb 22, 2011·Chemical Biology & Drug Design·Murat SentürkClaudiu T Supuran
Jun 15, 2011·Bioorganic & Medicinal Chemistry Letters·Sevim Beyza Oztürk SarikayaClaudiu T Supuran
Aug 3, 2011·Future Medicinal Chemistry·Claudiu T Supuran
Apr 4, 2012·Journal of Enzyme Inhibition and Medicinal Chemistry·Meryem NarAbdullah Menzek
Nov 6, 2012·Food Chemistry·Ali AtaseverO Irfan Kufrevioglu
Jan 15, 2013·Journal of Enzyme Inhibition and Medicinal Chemistry·Yusuf AkbabaClaudiu T Supuran
Feb 12, 2013·Bioorganic & Medicinal Chemistry·Akın AkıncıoğluClaudiu T Supuran
Mar 16, 2013·Expert Opinion on Therapeutic Patents·Fabrizio Carta, Claudiu T Supuran
Apr 30, 2013·Bioorganic & Medicinal Chemistry·Kadir AksuClaudiu T Supuran
Jun 26, 2014·Journal of Enzyme Inhibition and Medicinal Chemistry·Hülya GöçerClaudiu T Supuran
Jul 12, 2014·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Betul ArabaciSaleh Alwasel
Aug 1, 2014·Future Medicinal Chemistry·Fabrizio CartaAndrea Scozzafava
Jan 15, 2015·Journal of Enzyme Inhibition and Medicinal Chemistry·Andrea ScozzafavaSaleh H Alwasel
Apr 13, 2015·Bioorganic & Medicinal Chemistry·Alper YıldırımClaudiu T Supuran
May 10, 2015·Bioorganic Chemistry·Necla Öztaşkınİlhami Gülçin
Jun 30, 2016·Journal of Enzyme Inhibition and Medicinal Chemistry·Taner GokcenAhmet C Goren
Dec 6, 2016·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Anastasia KariotiClaudiu T Supuran
Dec 17, 2016·International Journal of Biological Macromolecules·Fevzi TopalMurat Guney
Apr 27, 2017·Journal of Biochemical and Molecular Toxicology·Zübeyir Huyutİlhami Gülçin
Nov 14, 2017·Journal of Biochemical and Molecular Toxicology·Cuneyt Caglayan, İlhami Gulcin
Feb 20, 2018·Journal of Biochemical and Molecular Toxicology·Fikret Türkanİlhami Gülçin
Jun 12, 2018·Expert Opinion on Therapeutic Patents·İlhami Gulçin, Parham Taslimi

❮ Previous
Next ❯

Citations

Aug 14, 2019·Dento Maxillo Facial Radiology·Hugo Gaêta-AraujoChristiano de Oliveira-Santos

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.